Laura Harris: Unfiltered

As AI adoption surges, it creates critical security blind spots. A burgeoning deep observability market, led by Gigamon, offers the essential solution.

Moving past generic platforms, specialized AI is generating measurable results in micro-industries, from reducing claim denials to slashing network downtime.

GE Lighting's latest launch isn't just about new bulbs. It's a strategic play balancing sculptural design with scientific precision for the modern home.

With a $24M Series A, AnySignal is modernizing mission-critical infrastructure. How will its software-defined radios reshape space and national security?

Hapag-Lloyd renews a key $550M funding facility, revealing a critical strategy for financial resilience in the turbulent global shipping industry.

Ashika Investment Managers launches a fund to capture India's next growth wave. Can its disciplined, data-driven strategy unlock value in a volatile market?

Beyond a simple transaction, Foresight Group's ongoing share repurchase signals deep confidence and a commitment to disciplined capital management.

Global investor EQT’s majority stake in PropertyMe signals a new era of AI-driven growth and consolidation for the ANZ property management software market.

A new fintech firm is using AI and non-custodial loans to bring instant liquidity to the art world's overlooked mid-market. Will it transform art into a dynamic asset?

Amex's $20k grants for Toronto & Montreal eateries are more than charity; they're a strategic investment in urban vibrancy and small business resilience.

Beyond the price surge, a deeper shift is underway. Discover how institutional adoption and artificial intelligence are fundamentally reshaping the crypto landscape.

Kayla's Children Centre is launching a year-round, medically-integrated camp, creating a new blueprint for disability care and a unique market opportunity.

Once overlooked, the HER3 protein is now a prime target for a new wave of immunotherapies, promising to overcome treatment resistance in major cancers.

Legend Biotech's award-winning investment in Ghent, Belgium, is more than a corporate win—it's scaling a cancer therapy revolution.

A new report reveals 632 cancer antibody deals since 2016. We analyze the multi-billion-dollar partnerships driving the next wave of cancer therapy.

Facing steep revenue decline from customer churn, Boardwalktech bets on aggressive cost cuts and an AI-powered platform pivot to survive. Is it enough?

The Smart TV market is set to triple, but the real story is the strategic war to become the central brain of your home. Who is winning, and what's next?

As direct subsidies wane, China's electric bus industry is not slowing down. It's accelerating into autonomous tech and global markets. What's next?

A new survey reveals a stunning consensus: 80% of Hill aides want to keep the filibuster. What do these legislative insiders know that the public doesn't?

Online travel agencies are extending holiday sales, but are the deals as good as they seem? We analyze the strategies behind the discounts and what they mean.